trending Market Intelligence /marketintelligence/en/news-insights/trending/IXuVHKTIkZpswVAhLCQ9uw2 content esgSubNav
In This List

Avrobio CFO, chief medical officer to step down; replacement CFO named

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Avrobio CFO, chief medical officer to step down; replacement CFO named

Avrobio Inc. said Katina Dorton and Nerissa Kreher are stepping down as CFO and chief medical officer of the company, respectively.

Erik Ostrowski will replace Dorton as CFO of the company, effective January 2019. Ostrowski was previously CFO of Summit Therapeutics PLC.

Meanwhile, Kreher will continue as a clinical adviser to Avrobio in a transitional role during the first quarter of 2019.

Cambridge, Mass.-based Avrobio develops gene therapies for treating rare diseases.